Clinical trial

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

NCT00070837

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2003-10-01Date precision: month

Registry last updated2007-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

MLN2704 (DM1 conjugated monoclonal antibody MLN591)DRUG

Sponsors & collaborators

Millennium Pharmaceuticals, Inc.lead sponsor

Mapped research locations

New YorkNew York, United States2 ClevelandOhio, United States1 DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00070837 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.